127 related articles for article (PubMed ID: 15309202)
1. C-reactive protein incites atherosclerosis.
Verma S
Can J Cardiol; 2004 Aug; 20 Suppl B():29B-31B. PubMed ID: 15309202
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein is an essential aspect of cardiovascular risk factor stratification.
Yeh ET
Can J Cardiol; 2004 Aug; 20 Suppl B():93B-96B. PubMed ID: 15309212
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
Koenig W
Ital Heart J; 2001 Mar; 2(3):157-63. PubMed ID: 11305526
[TBL] [Abstract][Full Text] [Related]
4. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein: a new risk assessment tool for cardiovascular disease.
Clearfield MB
J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
8. Endothelial function: ready for prime time?
Verma S; Szmitko PE; Anderson TJ
Can J Cardiol; 2004 Nov; 20(13):1335-9. PubMed ID: 15565197
[TBL] [Abstract][Full Text] [Related]
9. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) and the link between atherosclerosis and thrombosis.
Koschinsky ML
Can J Cardiol; 2004 Aug; 20 Suppl B():37B-43B. PubMed ID: 15309204
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and atherothrombosis.
Pepys MB; Hirschfield GM
Ital Heart J; 2001 Mar; 2(3):196-9. PubMed ID: 11305531
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
Piechota W; Piechota W
Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein and its role in the pathogenesis of myocardial infarction.
Pepys MB; Hirschfield GM
Ital Heart J; 2001 Nov; 2(11):804-6. PubMed ID: 11770862
[TBL] [Abstract][Full Text] [Related]
16. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
[TBL] [Abstract][Full Text] [Related]
17. The variable role of inflammation in acute coronary syndromes and in restenosis.
Biasucci LM; Liuzzo G; Buffon A; Maseri A
Semin Interv Cardiol; 1999 Sep; 4(3):105-10. PubMed ID: 10545616
[TBL] [Abstract][Full Text] [Related]
18. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
19. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
Koenig W
Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
[TBL] [Abstract][Full Text] [Related]
20. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
